Intermediate for Levomilnacipran. Levomilnacipran (trade name Fetzima) is a serotonin-norepinephrine reuptake inhibitor (SNRI). Levomilnacipran is the levorotatory enantiomer of milnacipran. Levomilnacipran is used as antidepressant for the treatment of major depressive disorder (MDD) in adults. Levomilnacipran has been approved by the U.S Food and Drug Administration on July 26, 2013.
Product Name: (1S,2R)-N,N-Diethyl-2-(hydroxymethyl)-1-phenylcyclopropanecarboxamide
CAS Number: 172015-99-5
Molecular Weight:  247.3364
Molecular Formula:  C15H21NO2
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.